Final results from a prospective, multicenter, non-interventional study (BESREMI-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia vera

  • Veronika Buxhofer-Ausch (Speaker)

Activity: Talk or presentationPoster presentationscience-to-science

Period06 Dec 2025
Event title67th ASH Annual Meeting and exposition
Event typeConference
LocationVereinigte Staaten, United StatesShow on map

Fields of science

  • 302 Clinical Medicine